全文获取类型
收费全文 | 773篇 |
免费 | 61篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 1篇 |
妇产科学 | 2篇 |
基础医学 | 26篇 |
口腔科学 | 3篇 |
临床医学 | 80篇 |
内科学 | 103篇 |
皮肤病学 | 3篇 |
神经病学 | 8篇 |
特种医学 | 68篇 |
外国民族医学 | 3篇 |
外科学 | 66篇 |
综合类 | 164篇 |
预防医学 | 18篇 |
眼科学 | 1篇 |
药学 | 83篇 |
中国医学 | 44篇 |
肿瘤学 | 169篇 |
出版年
2023年 | 4篇 |
2022年 | 11篇 |
2021年 | 25篇 |
2020年 | 21篇 |
2019年 | 29篇 |
2018年 | 29篇 |
2017年 | 44篇 |
2016年 | 25篇 |
2015年 | 33篇 |
2014年 | 69篇 |
2013年 | 75篇 |
2012年 | 54篇 |
2011年 | 61篇 |
2010年 | 74篇 |
2009年 | 55篇 |
2008年 | 54篇 |
2007年 | 38篇 |
2006年 | 34篇 |
2005年 | 31篇 |
2004年 | 14篇 |
2003年 | 14篇 |
2002年 | 23篇 |
2001年 | 5篇 |
2000年 | 8篇 |
1999年 | 4篇 |
1998年 | 1篇 |
1996年 | 2篇 |
1994年 | 1篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1983年 | 2篇 |
排序方式: 共有842条查询结果,搜索用时 93 毫秒
1.
2.
3.
目的 探讨NDR评分与多发性肝癌肝切除术后经导管动脉化疗栓塞术(TACE)疗效的关系。方法 回顾性分析2009年3月至2015年3月在海军军医大学东方肝胆外科医院行肝切除术的505例多发性肝癌病人的临床资料。根据术后是否行辅助性TACE将病人分为TACE组(n=272)和非TACE组(n=233),采用倾向得分匹配(PSM)对病人行1∶1配对。应用Kaplan-Meier法分析术后无复发存活率(RFS)和总体存活率(OS)的差异,并分析NDR评分与TACE疗效的关系。结果 PSM后,TACE组1、3、5年RFS和OS均高于非TACE组(66.8%、41.2%和27.6%;49.6%、37.2%和27.7%,P=0.031;86.1%、63.7%和42.6%;69.1%、49.0%和37.2%,P=0.002)。NDR评分≤2分时,TACE 组1、3、5年RFS和OS与非 TACE 组差异无统计学意义(68.6%、44.1%、29.0% vs. 58.0%、43.3%、35.2%,P=0.445;88.3%、65.0%、44.4% vs. 76.4%、55.0%、45.7%,P=0.109);NDR评分>2分时,TACE 组1、3、5年RFS和OS均高于非TACE组(60.5%、34.2%、28.5% vs. 20.3%、16.2%、8.1%,P=0.001;78.9%、51.6%、42.8% vs. 43.8%、29.9%、15.9%,P=0.007)。PSM后NDR评分>2分时,多因素分析显示,甲胎蛋白(AFP)和辅助性TACE是无复发生存的独立影响因素(HR=1.90、0.43;P<0.05);AFP、肿瘤最大最小径比值和辅助性TACE是总体生存的独立影响因素(HR=2.23、2.96、0.53;P<0.05)。结论 NDR评分>2分时,肝癌肝切除术后行辅助性TACE可有效减少术后复发,改善远期生存。对NDR评分>2分的多发性肝癌病人,推荐辅助性TACE作为术后抗复发治疗手段。 相似文献
4.
Kun Ma Jiayun Liu Youjin Wang Yubin Zhong Zhenfeng Wu Ruiying Fan Shanfeng Guo 《Journal of gastrointestinal oncology.》2020,11(6):1350
BackgroundOur study aims to investigate changes in cell-free DNA (cfDNA) concentration and integrity in primary hepatocellular carcinoma (PHC) patients before and after transcatheter arterial chemoembolization (TACE) treatment and their influence on the evaluation of prognosis of the disease.MethodsA total of 84 PHC patients admitted to the Affiliated Hospital of Nanjing University of Chinese Medicine from December 2016 to December 2017 were included as the study group, while 55 healthy people served as the control group. Plasma cfDNA concentration and integrity were determined using qRT-PCR. The correlation between cfDNA concentration/integrity and clinical characteristics of PHC patients were analyzed. A ROC curve was used to investigate the sensitivity and specificity of cfDNA as detection indices. Univariate and multivariate analyses were used to analyze factors affecting recurrence in PHC patients and compare recurrence-free survival (RFS) of PHC patients with high cfDNA expression and low cfDNA expression.ResultsPlasma cfDNA concentration and integrity were significantly higher in PHC patients before TACE treatment than in healthy people and significantly lower after treatment than before (P<0.05). The cfDNA concentration was significantly correlated with tumor size, lymph node metastasis, TNM stage, and BCLC stage, while cfDNA integrity was significantly correlated with tumor size, TNM stage, and BCLC stage (P<0.05). ROC results showed that the area under the curve (AUC) value of cfDNA concentration was the largest, with an optimal cut-off of 10.51 ng/mL. Multivariate regression analysis for COX showed that the TNM stage, cfDNA concentration, and AFP were independent risk factors that affected PHC patients’ survival.ConclusionsPlasma cfDNA concentration in PHC patients is more sensitive and specific than any other tumor marker. It is an independent risk factor for PHC patients treated with TACE. Therefore, it is hypothesized cfDNA is a potential biomarker for prognostic evaluation of PHC patients treated with TACE. 相似文献
5.
6.
7.
《Surgery (Oxford)》2014,32(12):655-660
The liver is commonly affected by malignant tumours, both primary and secondary. The majority of liver tumours are diagnosed radiologically and MRI and CT scan are accurate at detecting even small tumours. Hepatocellular carcinoma (HCC) is the most common primary tumour and often presents on the background of liver cirrhosis. The curative options for HCC are liver resection and transplant. However non-curative management such as radiofrequency ablation (RFA) and trans-arterial chemo-embolization (TACE) can prolong survival in patients not suited to curative management. Cholangiocarcinoma is a less common malignancy but unfortunately has poorer outcomes. It affects the bile ducts and treatment relies on resection of the affected liver and biliary tree, requiring reconstruction of the biliary drainage system. Postoperative morbidity is high and long term survival is often short. Colorectal liver metastases (CLM) are the most common liver tumours. With improvements in preoperative chemotherapy and surgical techniques such as portal vein embolization (PVE) and two stage resections, curative resection with good long term outcomes are often achieved. 相似文献
8.
《Diagnostic and interventional imaging》2015,96(6):547-562
Radioembolization (RE) is a selective internal radiotherapy technique in which yttrium-90 blended microspheres are infused through the hepatic arteries. It is based on the fact that primary and secondary hepatic tumors are vascularized mostly by arterial blood flow whereas healthy hepatocytes obtain their blood supply mostly from the portal network. This enables high radiation doses to be delivered, sparing the surrounding non-malignant liver parenchyma. Most of the complications are caused by unexpected particles passing into the gastrointestinal tract through branches originating from the main hepatic arterial supply. Knowledge of this hepatic arterial network and of its variations and the technical considerations this raises are required in preparation for treatment. This work describes the specific anatomical features and techniques for this anatomy through recent literature illustrated by cases from our own experience. 相似文献
9.
《Diagnostic and interventional imaging》2015,96(11):1169-1175
Rationale and backgroundTransarterial chemoembolization (TACE) is the most frequently used palliative therapy for unresectable hepatocellular carcinoma (HCC). It is a safe and effective procedure with few major and minor complications. Rarely, biliary complications are also encountered following TACE. The goal of our study was to investigate the incidence and the presentation of biliary complications following TACE in patients with HCC.Material and methodsIn this retrospective study, data of patients with HCC who underwent TACE between June 2002 to December 2014 were obtained from the records. Their detailed information about the procedure of TACE, diagnosis of biliary complications and subsequent management details were reviewed.ResultOne hundred and sixty-eight patients with HCC underwent 305 procedures of TACE. Of these, biliary complications of various severities developed in 6 (3.6%) patients leading to an incidence of 1.9% (6/305). Minimal intrahepatic biliary dilatation (IHBD) occurred in three, biliary stricture in one and intrahepatic biloma in two patients. Supportive management was undertaken for IHBD patients while percutaneous aspiration and naso-biliary drainage was performed for the infected bilomas.ConclusionBiliary complications following TACE are infrequent. Diagnosis should be suspected clinically and confirmed with imaging. Treatment depends on the severity. Enforcing specific measures can minimize its frequency. 相似文献
10.
A. Fohlen J.P. Tasu H. Kobeiter J.M. Bartoli J.P. Pelage B. Guiu 《Diagnostic and interventional imaging》2018,99(9):527-535